Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Huang, Tao ^a   Chen, Xiaoying ^a   Hong, Qingxiao ^a   Deng, Zaichun ^a   Ma, Hongying ^a   Xin, Yanfei ^b   Fang, Yong ^c   Ye, Huadan ^a   Wang, Rujie ^a   Zhang, Cheng ^a   Ye, Meng ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; TUMOR PROTEIN;

CHINA; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; GENETICS; HUMAN; JAPAN; MALE; META ANALYSIS; NON SMALL CELL LUNG CANCER; PATHOLOGY; SMOKING;

BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; JAPAN; MALE; NEOPLASM PROTEINS; SMOKING;

EID: 84924359085     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08897     Document Type: Article

References (37)

1. Takeda, K., Hida, T., Sato, T., Ando, M., Seto, T., Satouchi, M. et al. Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: Results of a west Japan thoracic oncology group trial (WJTOG0203). J Clin Oncol 28, 753-60 (2010).
2. Pao, W. & Chmielecki, J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10, 760-74 (2010).
3. Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H. & Zou, X. Report of cancer incidence and mortality in China, 2010. Ann Transl Med 2, 61 (2014).
4. Siegel, R.,Naishadham,D.&Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10-29 (2012).
5. Byers, L A. & Rudin, C. M. Small cell lung cancer: Where do we go from here? Cancer (2014).
6. Xie, D., Lan, L., Huang, K., Chen, L., Xu, C., Wang, R. et al. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients. Oncol Rep 32, 2517-26 (2014).
7. Tessema, M., Yingling, C. M., Liu, Y., Tellez, C. S., Van Neste, L., Baylin, S. S. et al. Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers. Carcinogenesis 35, 1248-57 (2014).
8. Tessema,M., Yu, Y. Y., Stidley, C. A.,Machida, E. O., Schuebel, K. E., Baylin, S. B. et al. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis 30, 1132-8 (2009).
9. Kwon, Y. J., Lee, S. J., Koh, J. S., Kim, S. H., Lee,H.W., Kang,M. C. et al. Genomewide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol 7, 20-33 (2012).
10. Yanagawa, N., Tamura, G., Oizumi, H., Endoh,M., Sadahiro, M. &Motoyama, T. Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: Relation with smoking status. Anticancer Res 31, 1211-4 (2011).
11. Nakata, S., Sugio, K., Uramoto, H., Oyama, T., Hanagiri, T., Morita, M. et al. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: Epigenetic silencing, clinical features, and prognostic significance. Cancer 106, 2190-9 (2006).
12. Jiang, H., Sun, M. W., Hefright, B., Chen, W., Lu, C. D. & Zeng, J. Efficacy of hypocaloric parenteral nutrition for surgical patients: A systematic review and meta-analysis. Clin Nutr 30, 730-7 (2011).
13. Coory, M. D. Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 39, 932 (2010).
14. Gates, P., Jaffe, A. & Copeland, J. Cannabis smoking and respiratory health: Consideration of the literature. Respirology 19, 655-62 (2014).
15. Xie, A., Croce, B. & Tian, D. H. Smoking and lung cancer. Ann Cardiothorac Surg 3, 221 (2014).
16. Tan, Q.,Wang, G., Huang, J., Ding, Z., Luo, Q.,Mok, T. et al. Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking. Onco Targets Ther 6, 1471-9 (2013).
17. Suda, K., Tomizawa, K., Yatabe, Y. & Mitsudomi, T. Lung cancers unrelated to smoking: Characterized by single oncogene addiction? Int J Clin Oncol 16, 294-305 (2011).
18. Uimonen, K., Merikallio, H., Paakko, P., Harju, T., Mannermaa, A., Palvimo, J. et al. GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma. Histol Histopathol 29, 797-804 (2014).
19. Massion, P. P., Zou, Y., Chen, H., Jiang, A., Coulson, P., Amos, C. I. et al. Smokingrelated genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med 178, 1164-72 (2008).
20. Ling, Q., Shi,W., Huang, C., Zheng, J., Cheng, Q., Yu, K. et al. Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma. Am J Cancer Res 4, 508-17 (2014).
21. Lin, R. K., Hsieh, Y. S., Lin, P., Hsu, H. S., Chen, C. Y., Tang, Y. A. et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120, 521-32 (2010).
22. Kobayashi, T., Wang, J., Al-Ahmadie, H. & Abate-Shen, C. ARF regulates the stability of p16 protein via REGgamma-dependent proteasome degradation. Mol Cancer Res 11, 828-33 (2013).
23. Jarmalaite, S., Kannio, A., Anttila, S., Lazutka, J. R. & Husgafvel-Pursiainen, K. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer 106, 913-8 (2003).
24. Beckedorff, F. C., Ayupe, A. C., Crocci-Souza, R., Amaral, M. S., Nakaya, H. I., Soltys,D. T. et al. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet 9, e1003705 (2013).
25. Ekim, M., Caner, V., Buyukpinarbasili, N., Tepeli, E., Elmas, L. & Bagci, G. Determination of O(6)-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Genet Test Mol Biomarkers 15, 357-60 (2011).
26. Word, B., Lyn-Cook, L. E., Jr.,Mwamba, B.,Wang, H., Lyn-Cook, B.&Hammons, G. Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20 lung cells in vitro: Short-term and chronic exposure. Int J Toxicol 32, 23-31 (2013).
27. Evans, T. R. & Kaye, S. B. Retinoids: Present role and future potential. Br J Cancer 80, 1-8 (1999).
28. Moison, C., Senamaud-Beaufort, C., Fourriere, L., Champion, C., Ceccaldi, A., Lacomme, S. et al. DNA methylation associated with polycomb repression in retinoic acid receptor beta silencing. FASEB J 27, 1468-78 (2013).
29. Ye,M., Li, D., Zhou, F., Guo, Q.&Xia, B. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Eur J Cancer Prev 21, 241-6 (2012).
30. Hu, S. L., Kong, X. Y., Cheng, Z. D., Sun, Y. B., Shen, G., Xu, W. P. et al. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori 96, 726-33 (2010).
31. Kim, J. S., Kim, H., Shim, Y. M., Han, J., Park, J. & Kim, D. H. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 25, 2165-71 (2004).
32. Liu, Y. L., Yang, H. P., Zhou, X. D., Gong, L., Tang, C. L. & Wang, H. J. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-smallcell lung cancer. Curr Cancer Drug Targets 11, 1098-110 (2011).
33. Zhang, B., Zhu,W., Yang, P., Liu, T., Jiang, M., He, Z. N. et al. Cigarette smoking and p16INK4alpha gene promoter hypermethylation in non-small cell lung carcinoma patients: A meta-analysis. PLoS One 6, e28882 (2011).
34. Liu, W. J., Tan, X. H., Guo, B. P., Ke, Q., Sun, J. & Cen, H. Associations between RASSF1A promoter methylation and NSCLC: A meta-analysis of published data. Asian Pac J Cancer Prev 14, 3719-24 (2013).
35. Murphy, S. E., Park, S. S., Thompson, E. F.,Wilkens, L. R., Patel, Y., Stram, D. O. et al. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis 35, 2526-2533 (2014).
36. Siegel, R.,Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014).
37. Tantraworasin, A., Lertprasertsuke, N., Kongkarnka, S., Euathrongchit, J., Wannasopha, Y. & Saeteng, S. Retrospective study of ALK rearrangement and clinicopathological implications in completely resected non-small cell lung cancer patients in Northern Thailand: Role of screening with D5F3 antibodies. Asian Pac J Cancer Prev 15, 3057-63 (2014).